Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
Nature Reports Stem Cells
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Letter
Nature Genetics  34, 308 - 312 (2003)
Published online: 1 June 2003; | doi:10.1038/ng1170

Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2

Richard E Person1, 7, Feng-Qian Li2, 7, Zhijun Duan2, 7, Kathleen F Benson2, Jeremy Wechsler2, Helen A Papadaki3, George Eliopoulos3, Christina Kaufman4, Salvatore J Bertolone5, Betty Nakamoto6, Thalia Papayannopoulou6, H Leighton Grimes4 & Marshall Horwitz2

1  Department of Pathology, University of Washington School of Medicine, Box 357720, Seattle, Washington 98195, USA.

2  Division of Medical Genetics, Department of Medicine, University of Washington School of Medicine, Box 357720, Seattle, Washington 98195, USA.

3  Department of Hematology, University of Crete School of Medicine, University Hospital of Heraklion, P.O. Box 1352, Crete, Greece.

4  Institute for Cellular Therapeutics and Department of Surgery, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.

5  Division of Hematology/Oncology, Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.

6  Division of Hematology, Department of Medicine, University of Washington School of Medicine, Box 357720, Seattle, Washington 98195, USA.

7  These authors contributed equally to this work.

Correspondence should be addressed to Marshall Horwitz horwitz@u.washington.edu
Mice lacking the transcriptional repressor oncoprotein Gfi1 are unexpectedly neutropenic1, 2. We therefore screened GFI1 as a candidate for association with neutropenia in affected individuals without mutations in ELA2 (encoding neutrophil elastase), the most common cause of severe congenital neutropenia (SCN; ref. 3). We found dominant negative zinc finger mutations that disable transcriptional repressor activity. The phenotype also includes immunodeficient lymphocytes and production of a circulating population of myeloid cells that appear immature. We show by chromatin immunoprecipitation, gel shift, reporter assays and elevated expression of ELA2 in vivo in neutropenic individuals that GFI1 represses ELA2, linking these two genes in a common pathway involved in myeloid differentiation.


 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy